PharmaCielo Ltd. (PCLO.V)
CAD 0.06
(-15.38%)
CAD 0.06
(-15.38%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -9.7 Million CAD | 7.88% |
| 2022 | -11.45 Million CAD | 55.0% |
| 2021 | -25.46 Million CAD | 40.95% |
| 2020 | -43.12 Million CAD | -26.96% |
| 2019 | -33.96 Million CAD | -28535.79% |
| 2018 | -118.6 Thousand CAD | -642.21% |
| 2017 | -15.98 Thousand CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -1.59 Million CAD | 3.99% |
| 2024 Q1 | -1.69 Million CAD | 52.59% |
| 2023 Q4 | -3.58 Million CAD | -59.87% |
| 2023 Q2 | -2.97 Million CAD | 1.26% |
| 2023 FY | -10.55 Million CAD | 7.88% |
| 2023 Q3 | -2.24 Million CAD | 24.68% |
| 2023 Q1 | -3.01 Million CAD | -226.87% |
| 2022 Q2 | -3.02 Million CAD | -9.58% |
| 2022 Q4 | -921.93 Thousand CAD | 80.04% |
| 2022 FY | -11.45 Million CAD | 55.0% |
| 2022 Q1 | -2.76 Million CAD | 25.87% |
| 2022 Q3 | -4.61 Million CAD | -52.43% |
| 2021 Q1 | -7 Million CAD | 66.63% |
| 2021 FY | -25.46 Million CAD | 40.95% |
| 2021 Q4 | -3.72 Million CAD | 54.6% |
| 2021 Q3 | -8.21 Million CAD | -27.91% |
| 2021 Q2 | -6.42 Million CAD | 8.32% |
| 2020 Q4 | -20.99 Million CAD | -217.34% |
| 2020 Q3 | -6.61 Million CAD | 12.48% |
| 2020 Q1 | -6.92 Million CAD | 39.37% |
| 2020 Q2 | -7.55 Million CAD | -9.15% |
| 2020 FY | -43.12 Million CAD | -26.96% |
| 2019 Q1 | -8.15 Million CAD | -77355.61% |
| 2019 FY | -33.96 Million CAD | -28535.79% |
| 2019 Q4 | -11.42 Million CAD | -187.5% |
| 2019 Q3 | -3.97 Million CAD | -7.9% |
| 2019 Q2 | -3.68 Million CAD | 54.84% |
| 2018 Q3 | -37.11 Thousand CAD | -34.89% |
| 2018 FY | -118.6 Thousand CAD | -642.21% |
| 2018 Q1 | -44.08 Thousand CAD | -252.4% |
| 2018 Q2 | -27.51 Thousand CAD | 37.59% |
| 2018 Q4 | -10.52 Thousand CAD | 71.64% |
| 2017 FY | -15.98 Thousand CAD | 0.0% |
| 2017 Q4 | -12.51 Thousand CAD | 21.72% |
| 2017 Q3 | -15.98 Thousand CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | -2.82 Million CAD | -243.97% |
| CanadaBis Capital Inc. | 4.67 Million CAD | 307.423% |
| Decibel Cannabis Company Inc. | 1.41 Million CAD | 787.035% |
| Delivra Health Brands Inc. | -710 Thousand CAD | -1266.33% |
| Entourage Health Corp. | -21.37 Million CAD | 54.622% |
| Lifeist Wellness Inc. | -12.24 Million CAD | 20.809% |
| Cannara Biotech Inc. | 11.88 Million CAD | 181.604% |
| Medicure Inc. | -854 Thousand CAD | -1035.941% |
| Rubicon Organics Inc. | -1.08 Million CAD | -795.379% |
| BioSyent Inc. | 7.47 Million CAD | 229.846% |
| Voyageur Pharmaceuticals Ltd. | -1.22 Million CAD | -694.539% |